First National Daily eMedical Newspaper of India
Nobody Reports News Better Than Us  
Editorial
We have improved our eMediNexus Platform with a far superior user experience.
Please click here to try it
Editor-in-Chief eMediNexus – Dr KK Aggarwal
Editor-in-Chief eIMANews - Dr Ravi Wankhedkar
4th February, 2018
Cancer survival rates

Cancer survival rates or survival statistics are indicative of the percentage of people who survive a certain type of cancer for a specific amount of time. Cancer statistics often use an overall five-year survival rate, which is an estimation of the percentage of people who are still alive five years after their diagnosis. Survival also varies for different types of cancer and also for common cancers in males and in females. The 5-year survival is also calculated by the stage of the cancer at the time of diagnosis, whether it is confined to the organ affected or spread further. Survival rates also vary between the developed and developing countries.

  • The overall five-year survival rate for bladder cancer is 78%, this means that of all people who have bladder cancer, 78 of every 100 are living five years after diagnosis.
  • An estimated 52% of people diagnosed with early-stage lung cancer live for at least five years after diagnosis.
  • The five-year survival rate for people diagnosed with late-stage lung cancer that has spread (metastasized) to other areas of the body is 4%.... read more
Special
Top News

Today is World Cancer Day: "We can. I can."

World Cancer Day, observed every year on February 4, 2018 aims to save millions of preventable deaths each year by raising awareness and education about the disease, pressing governments and individuals across the world to take action. The theme "We can. I can" highlights how everyone – as a collective or as individuals ... read more


ASCO names CAR T-cell immunotherapy as the ‘Advance of the Year’ in its annual report

The American Society of Clinical Oncology (ASCO) has named CAR T-cell immunotherapy as the Advance of the Year in its annual report ‘Clinical Cancer Advances 2018’. In 2017, the US Food and Drug Administration (FDA) approved two CAR T-cell therapies, to treat children and young adults with acute lymphoblastic leukemia and adults with diffuse large B-cell lymphoma.... read more

Practice Updates

Stress and diet associated with brain bleeds

Los Angeles on January 26, the risk of brain bleeds related to high blood pressure was 2.22 times as high in people who reported more stress at home and work, while it was 64% lower in people who reported eating more green, leafy vegetables.... read more


US FDA expands indications of ceftazidime + avibactam for drug-resistant pneumonia

The US FDA has expanded the approved indications of Avycaz (ceftazidime and avibactam) to treat adults with hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by drug-resistant bacteria.... read more


Very low calorie diets may cause transient deterioration in heart function

New research presented at CMR 2018, the joint EuroCMR/ SCMR Meeting in Barcelona, Spain on February 2, 2018 suggests that crash diets can cause a transient deterioration in heart function including the heart’s ability to pump blood. Hence, patients with heart disease should seek medical advice before following a very low... read more


Anxious persons more at risk of dog bites, says study

Individuals scoring higher in emotional stability on the Ten Item Personality Inventory (TIPI) had a lower risk of having ever been bitten by a dog, according to the findings of a study published online February 1 in the Journal of Epidemiology and Community Health. Every single point increase in score between 1 and 7 was associated with a 23%.... read more


Study explores potential mechanisms behind decline in vascular events with empagliflozin

Data from a post-hoc analysis of the landmark EMPA-REG OUTCOME study show that changes in markers of plasma volume were the main factors causing a 38% decline in the risk of death due to vascular events with empagliflozin in patients with type 2 diabetes and established cardiovascular disease.... read more


Tranexamic acid immediately after vaginal delivery reduces PPH risk

Results of the TRAAP trial presented February 1, 2018 at the Society for Maternal-Fetal Medicine's Annual Pregnancy Meeting in Dallas show that among women who delivered vaginally and received prophylactic oxytocin, tranexamic acid was associated with a lower risk of postpartum bleeding than placebo without higher risk of severe adverse... read more

Recent Updates

The impact of third-trimester genetic counseling.

A new study published in the Archives of Gynecology and Obstetrics evaluated the impact of genetic counseling (GC) during the third trimester by analyzing changes in pregnancy.... read more


Effect of air bubbles localization and migration on assisted reproductive technology outcome.

A new study published in Fertility and Sterility evaluated the effect of embryo flash position and movement of the air bubbles at 1 and 60 minutes after embryo transfer (ET) on clinical.... read more

eMedi Humor
Medicolegal Corner
eMedi Quiz
a. A client with high blood pressure
b. A client with bowel obstruction
c. A client with glaucoma
d. A client with UTI
Lifestyle Updates
 
Inspirational Story 1: :Temper Control
Inspirational Story 2: Monetary Reminder
Retinoblastoma can be treated upon early detection
Several cancers are treatable, however, there still remains lack of awareness about this fact
 
New Delhi 3rd February 2018: A rare form of cancer, affecting only about 2,000 people in India per year, Retinoblastoma, is the most common among the cancers of the eye in children under the age of five. About 92% of such children live in the developing nations. Many children lose their eye sight or die from this cancer due to lack of awareness of the initial signs of presentation, poor access to proper treatment or lack of finances to finish the treatment.
 
Retinoblastoma is a cancer that starts in the retina, the very back part of the eye. It occurs when nerve cells in the retina develop genetic mutations. These mutations cause the cells to continue growing and multiplying when healthy cells would die. This accumulating mass of cells forms a tumor.
To Read More or Comment, Click Here